In Segment A, participants will get different doses and schedules of oral ABBV-744 tablet to establish Secure dosing routine. Supplemental participants might be enrolled at the discovered monotherapy dosign program. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be offered as "incorporate-on" therapy. In Section C, members https://tysondqblv.madmouseblog.com/12543554/details-fiction-and-abbv-744-in-acute-myeloid-leukemia-aml